ArticleScientific reports2025
Retrospective evaluation of oral complications following radiotherapy and chemoradiation in patients with head and neck Cancer.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Article
- The effectiveness of Annona muricata for improving induced oral candidiasis in gamma-irradiated rats.BMC complementary medicine and therapies · 2026Article
- Oral dryness related symptoms in radiation-treated head and neck cancer patients: a pilot study of oral microbiome composition and function.BMC microbiology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Patients receiving head and neck radiotherapy/chemoradiation may experience a notable and frequent decline in their oral health due to oral complications, including restricted mouth opening, oral mucositis, dry mouth, halitosis, infection, and oral pain. The main aim of this study was to describe the oral complications arising from post-Radiotherapy/chemoradiation among HNC patients through a retrospective survey of 80 patient records. This study collected patients' comorbid illness and treatment details alongside oral complications. The record review included one-year follow-up details of HNC patients post-completion of radiotherapy/chemoradiation. Among the 80 patients who completed head and neck radiotherapy, 23 experienced interrupted treatment. Among them, most (15%) did not tolerate chemotherapy, which is part of chemoradiation. Thirty-four patients were followed up for oral complications. Most patients experienced symptoms of restricted mouth opening 12(15%), mucositis 6(7.5%), and oral pain 5(6.25%) as oral complications during the subsequent follow-up. Approximately 14 patients reported HNC recurrence. These postradiotherapy/chemoradiation-related oral complications pose a difficult challenge to patients and their caregivers. Awareness of such oral complications will enable healthcare providers to recognize and institute early interventions to provide patients with a better quality of life.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.